XOMA and Takeda Establish Collaboration for Therapeutic Antibody Discovery and Development
November 02, 2006 03:05 ET
|
XOMA Corporation
BERKELEY, Calif. and OSAKA, Japan, Nov. 2, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA) and Takeda Pharmaceutical Company Limited (TSE4502:Takeda) today announced that they have entered into an...
XOMA Announces November 9 Conference Call and Webcast Discussion of Third Quarter 2006 Results
November 01, 2006 14:00 ET
|
XOMA Corporation
BERKELEY, Calif., Nov. 1, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA) will issue a news release announcing its third-quarter financial results for the quarter ended September 30, 2006, on Thursday,...
XOMA to Humanize Attenuon's Novel Anti-Cancer Antibody
October 03, 2006 09:00 ET
|
XOMA Corporation
BERKELEY, Calif. and SAN DIEGO, Oct. 3, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA) and Attenuon, LLC today announced an agreement for XOMA to utilize its Human Engineering(tm) (HE(tm)) technology to...
XOMA and Affimed Sign Antibody Cross-License and Collaboration Agreement
October 02, 2006 09:00 ET
|
XOMA Corporation
BERKELEY, Calif. and HEIDELBERG, Germany, Oct. 2, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA) and Affimed Therapeutics AG announced today that they have signed a cross-license and collaboration...
XOMA Announces Conference Presentation Schedule
September 29, 2006 18:04 ET
|
XOMA Corporation
BERKELEY, Calif., Sept. 29, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA) today announced its plans for its chief financial officer, Mr. David Boyle, to present an overview of its business strategy and...